BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Cancer Cachexia: Its Mechanism and Clinical Significance. Int J Mol Sci 2021;22:8491. [PMID: 34445197 DOI: 10.3390/ijms22168491] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Cernackova A, Tillinger A, Bizik J, Mravec B, Horvathova L. Dynamics of cachexia-associated inflammatory changes in the brain accompanying intra-abdominal fibrosarcoma growth in Wistar rats. Journal of Neuroimmunology 2023. [DOI: 10.1016/j.jneuroim.2023.578033] [Reference Citation Analysis]
2 Yang T, Gokulnath P, Meng X, Li G, Xiao J. Genome Editing to Abrogate Muscle Atrophy. Advances in Experimental Medicine and Biology 2023. [DOI: 10.1007/978-981-19-5642-3_11] [Reference Citation Analysis]
3 Pandit P, Panigrahi S. Probing the Biology of Zinc Alpha2-Glycoprotein and the role it plays in cachexia.. [DOI: 10.1101/2022.12.14.520465] [Reference Citation Analysis]
4 Kwak JH, Eun CS, Han DS, Kim YS, Song KS, Choi BY, Kim HJ. Sex-dependent associations between MAP3K1 gene polymorphisms and soy products with the gastric cancer risk in Korea: a case-control study. BMC Gastroenterol 2022;22:513. [PMID: 36510163 DOI: 10.1186/s12876-022-02569-3] [Reference Citation Analysis]
5 Zarifi SH, Bagherniya M, Banach M, Johnston TP, Sahebkar A. Phytochemicals: A potential therapeutic intervention for the prevention and treatment of cachexia. Clin Nutr 2022;41:2843-57. [PMID: 36403384 DOI: 10.1016/j.clnu.2022.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang Y, An Z, Lin D, Jin W. Targeting cancer cachexia: Molecular mechanisms and clinical study. MedComm 2022;3. [DOI: 10.1002/mco2.164] [Reference Citation Analysis]
7 Zhang L, Guan J, Ding C, Feng M, Gong L, Guan W. Muscle loss 6 months after surgery predicts poor survival of patients with non-metastatic colorectal cancer. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1047029] [Reference Citation Analysis]
8 Takemoto K, Sekino Y, Kitano H, Ikeda K, Goto K, Hieda K, Hayashi T, Hasegawa Y, Kato M, Kadonishi Y, Kajiwara M, Teishima J, Mita K, Maruyama S, Shigeta M, Hinata N. Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first‐line tyrosine kinase inhibitors. Int J of Urology 2022. [DOI: 10.1111/iju.15110] [Reference Citation Analysis]
9 Chen L, Xia L, Zhang J, Wang Y, Chen J, Guo C, Xu W. Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3. Phytotherapy Research 2022. [DOI: 10.1002/ptr.7676] [Reference Citation Analysis]
10 Jiang X, Ji S, Cui S, Wang R, Wang W, Chen Y, Zhu S. Apol9a regulates myogenic differentiation via the ERK1/2 pathway in C2C12 cells. Front Pharmacol 2022;13:942061. [PMID: 36506560 DOI: 10.3389/fphar.2022.942061] [Reference Citation Analysis]
11 Ikegami T, Nishikawa H, Goto M, Shimamoto F, Terazawa T, Yamaguchi T, Yamasaki E, Asaishi K, Nakamura S, Higuchi K. Prognostic Impact of Ectopic Fat Deposition within Psoas Muscle in Stage IV Gastric Cancer Patients Undergoing Systemic Chemotherapy. J Cancer 2022;13:3477-84. [PMID: 36313034 DOI: 10.7150/jca.78407] [Reference Citation Analysis]
12 Lazarus E, Bays HE. Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022;3:100026. [DOI: 10.1016/j.obpill.2022.100026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chang L, Cheng Q, Ma Y, Wu C, Zhang X, Ma Q, He L, Li Q, Tao J. Prognostic Effect of the Controlling Nutritional Status Score in Patients With Esophageal Cancer Treated With Immune Checkpoint Inhibitor. J Immunother 2022. [PMID: 36006239 DOI: 10.1097/CJI.0000000000000438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Huang X, Luo J, Baldinger B. The controlling nutritional status score and clinical outcomes in patients with heart failure: Pool analysis of observational studies. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.961141] [Reference Citation Analysis]
15 Braha A, Albai A, Timar B, Negru Ș, Sorin S, Roman D, Popovici D. Nutritional Interventions to Improve Cachexia Outcomes in Cancer—A Systematic Review. Medicina 2022;58:966. [DOI: 10.3390/medicina58070966] [Reference Citation Analysis]
16 Liu C, Zhang Q, Ruan G, Shen L, Xie H, Liu T, Tang M, Zhang X, Yang M, Hu C, Zhang K, Liu X, Shi H. Novel Diagnostic and Prognostic Tools for Lung Cancer Cachexia: Based on Nutritional and Inflammatory Status. Front Oncol 2022;12:890745. [DOI: 10.3389/fonc.2022.890745] [Reference Citation Analysis]
17 Olaechea S, Gannavarapu BS, Alvarez C, Gilmore A, Sarver B, Xie D, Infante R, Iyengar P. Primary Tumor Fluorine‐18 Fluorodeoxydglucose (18F‐FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival. Front Oncol 2022;12:900712. [DOI: 10.3389/fonc.2022.900712] [Reference Citation Analysis]
18 Zeng R, Tong C, Xiong X. The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia. Cancers (Basel) 2022;14:2955. [PMID: 35740622 DOI: 10.3390/cancers14122955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Asaishi K, Matsui M, Nishikawa H, Goto M, Asai A, Ushiro K, Ogura T, Takeuchi T, Nakamura S, Kakimoto K, Miyazaki T, Fukunishi S, Ohama H, Yokohama K, Yasuoka H, Higuchi K. Grip Strength in Patients with Gastrointestinal Diseases. JCM 2022;11:2079. [DOI: 10.3390/jcm11082079] [Reference Citation Analysis]
20 Yamasaki E, Nishikawa H, Goto M, Matsui M, Asai A, Ushiro K, Ogura T, Takeuchi T, Nakamura S, Kakimoto K, Miyazaki T, Fukunishi S, Ohama H, Yokohama K, Yasuoka H, Higuchi K. The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases. J Clin Med 2022;11:2012. [PMID: 35407620 DOI: 10.3390/jcm11072012] [Reference Citation Analysis]
21 Ikegami T, Nishikawa H, Goto M, Matsui M, Asai A, Ushiro K, Ogura T, Takeuchi T, Nakamura S, Kakimoto K, Miyazaki T, Fukunishi S, Ohama H, Yokohama K, Yasuoka H, Higuchi K. The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases. JCM 2022;11:582. [DOI: 10.3390/jcm11030582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Connolly-schoonen J, Biamonte SF, Danowski L, Montrose DC. Modifying dietary amino acids in cancer patients. International Review of Cell and Molecular Biology 2022. [DOI: 10.1016/bs.ircmb.2022.02.004] [Reference Citation Analysis]
23 McMillin SL, Minchew EC, Lowe DA, Spangenburg EE. Skeletal muscle wasting: the estrogen side of sexual dimorphism. Am J Physiol Cell Physiol 2022;322:C24-37. [PMID: 34788147 DOI: 10.1152/ajpcell.00333.2021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
24 Matsui M, Nishikawa H, Goto M, Asai A, Ushiro K, Ogura T, Takeuchi T, Nakamura S, Kakimoto K, Miyazaki T, Fukunishi S, Ohama H, Yokohama K, Yasuoka H, Higuchi K. Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers. Cancers (Basel) 2021;14:10. [PMID: 35008175 DOI: 10.3390/cancers14010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Bell D. Cachexia. Radiopaedia.org 2021. [DOI: 10.53347/rid-95218] [Reference Citation Analysis]
26 Wijaya YT, Setiawan T, Sari IN, Nah SY, Kwon HY. Amelioration of muscle wasting by gintonin in cancer cachexia. Neoplasia 2021;23:1307-17. [PMID: 34798386 DOI: 10.1016/j.neo.2021.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]